Terms of Service
Please read these terms carefully before using our platform
By accessing and using Dabro.fr (the "Platform"), you agree to be bound by these Terms of Service. If you do not agree with any part of these terms, you must not use our Platform.
Platform Purpose and Scope
Dabro.fr is a clinical research and drug development information platform. We provide:
- ✓Information about experimental drugs in development (preclinical to Phase 4)
- ✓Clinical trial tracking and research publications
- ✓Scientific discussions for researchers and medical professionals
Critical Medical Disclaimer
THIS IS NOT MEDICAL ADVICE
- •All information is for research and educational purposes only
- •Experimental drugs listed are NOT approved for general clinical use
- •We do NOT provide medical consultations or treatment recommendations
- •ALWAYS consult qualified healthcare professionals before making medical decisions
User Responsibilities
- •You must provide accurate and truthful information when creating an account
- •You are responsible for maintaining the confidentiality of your account credentials
- •You must not use the Platform for any unlawful purposes
- •You must not attempt to gain unauthorized access to any part of the Platform
- •You agree to use the Platform in compliance with all applicable laws and regulations
User-Generated Content (Forum)
When participating in our scientific community forum, you agree to the following:
Content Guidelines
- ✓Maintain scientific rigor and cite sources for research claims
- ✓Respect professional discourse and academic integrity
- ✓Do not post unverified medical claims or personal medical advice
Prohibited Content
- ✗Misinformation or unsubstantiated medical claims
- ✗Personal attacks, harassment, or discriminatory content
- ✗Spam, advertising, or commercial solicitations
- ✗Content that violates intellectual property rights
Content Moderation
We reserve the right to review, edit, or remove any user-generated content that violates these Terms of Service or our Community Guidelines. Repeated violations may result in account suspension or termination.
We operate a three-strike warning system for policy violations.
Intellectual Property
All research content, experimental drug data, clinical trial information, and platform design are protected by copyright and intellectual property laws. You may not reproduce, distribute, or create derivative works without our express written permission.
You retain ownership of content you post in the forum but grant us a non-exclusive license to display and distribute it on the Platform.
Limitation of Liability
To the maximum extent permitted by law, Dabro.fr and its operators shall not be liable for:
- •Any damages arising from reliance on research information provided on the Platform
- •Medical outcomes or decisions made based on experimental drug information
- •Inaccuracies in third-party research data (ClinicalTrials.gov, peer-reviewed journals)
Changes to Terms
We may update these Terms of Service from time to time. We will notify users of significant changes via email or prominent notice on the Platform. Continued use of the Platform after changes constitutes acceptance of the updated terms.
Legal Contact
For questions about these Terms of Service, please contact our legal team:
Email: legal@dabro.fr